Binding of the novel radioligand [3H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors

被引:18
|
作者
Ibba, Massimo [1 ,2 ,3 ]
Kitayama, Masato [1 ]
McDonald, John [1 ]
Calo, Girolamo [2 ,3 ]
Guerrini, Remo [4 ,5 ]
Farkas, Judit [6 ]
Toth, Geza [6 ]
Lambert, David G. [1 ]
机构
[1] Univ Leicester, Div Anaesthesia Crit Care & Pain Management, Dept Cardiovasc Sci, Leicester Royal Infirm,Pharmacol & Therapeut Grp, Leicester LE1 5WW, Leics, England
[2] Univ Ferrara, Dept Expt & Clin Med, Pharmacol Sect, I-44100 Ferrara, Italy
[3] Univ Ferrara, Natl Inst Neurosci, I-44100 Ferrara, Italy
[4] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy
[5] Univ Ferrara, Ctr Biotechnol, I-44100 Ferrara, Italy
[6] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary
关键词
Nociceptin; Orphanin FQ; NOP receptor; Radiolabeled Nociceptin; Orphanin FQ receptor antagonist [H-3]UFP-101; Radioligand binding; Guanine nucleotides;
D O I
10.1007/s00210-008-0350-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nociceptin/orphanin FQ (N/OFQ) is the endogenous ligand for the N/OFQ peptide receptor (NOP). Binding studies have relied on [leucyl-H-3]N/OFQ, but as this is an agonist G-protein coupling will affect affinity. In this paper, we describe a new [H-3]labeled NOP antagonist, [Nphe(1), 4'-H-3-Phe(4),Arg(14),Lys(15)]N/OFQ-NH2 ([H-3]UFP-101). We have characterized [H-3]UFP-101 at recombinant human NOP expressed in Chinese hamster ovary cells (CHOhNOP) and native rat NOP in cerebrocortex. Radioligand saturation and competition studies were performed on membranes, and [H-3]UFP-101 (antagonist) was compared with [H-3]N/OFQ (agonist). The effects of GTP gamma S (10 mu M) and Na+ were investigated alone and in combination in competition experiments with both radioligands. In CHOhNOP, B (max), and pK (D), values were 561 and 580 fmol mg protein(-1) and 9.97 and 10.19 for [H-3]UFP-101 and [leucyl-H-3]N/OFQ, respectively. In rat cerebrocortex B (max) and pK (D), values were 65 and 88 fmol mg protein(-1) and 10.12 and 10.34 for [H-3]UFP-101 and [leucyl-H-3]N/OFQ. The binding of both radioligands was displaced by a range of peptide and non-peptide NOP ligands at both isoforms with good correlation (r(2) 0.92 in Rat and 0.97 in CHOhNOP). Naloxone was inactive. The binding of both radioligands was Na+ dependent with [H-3]UFP-101 being more sensitive (IC50 similar to 20 mM). Unlike the agonist [leucyl-H-3]N/OFQ, the antagonist [H-3]UFP-101 was unaffected by GTP gamma S. [H-3]UFP-101 binds to human and rat NOP with high affinity and good agreement with standard [leucyl-H-3]N/OFQ in competition experiments. In addition, the binding of [H-3]UFP-101 is unaffected by GTP gamma S. This radioligand will be useful to further characterize NOP in a range of binding paradigms.
引用
收藏
页码:553 / 561
页数:9
相关论文
共 50 条
  • [1] Binding of the novel radioligand [3H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors
    Massimo Ibba
    Masato Kitayama
    John McDonald
    Girolamo Calo
    Remo Guerrini
    Judit Farkas
    Geza Toth
    David G. Lambert
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2008, 378 : 553 - 561
  • [2] Pharmacological characterization of [3H]UFP-101, a novel radioligand selective for the nociceptin/orphanin FQ receptor
    Ibba, M
    Calo, G
    Guerrini, R
    Toth, G
    Lambert, DG
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 : U111 - U111
  • [3] UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor
    Calo, G
    Guerrini, R
    Rizzi, A
    Salvadori, S
    Burmeister, M
    Kapusta, DR
    Lambert, DG
    Regoli, D
    CNS DRUG REVIEWS, 2005, 11 (02): : 97 - 112
  • [4] UFP-101, a high affinity antagonist for the nociceptin/orphanin FQ receptor:: radioligand and GTPγ35S binding studies
    McDonald, J
    Calo, G
    Guerrini, R
    Lambert, DG
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 (02) : 183 - 187
  • [5] UFP-101, a high affinity antagonist for the nociceptin/orphanin FQ receptor: radioligand and GTPγ35S binding studies
    J. McDonald
    G. Calo
    R. Guerrini
    D. G. Lambert
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2003, 367 : 183 - 187
  • [6] The Nociceptin/Orphanin FQ Receptor Antagonist UFP-101 Reduces Microvascular Inflammation to Lipopolysaccharide In Vivo
    Brookes, Zoe L. S.
    Stedman, Emily N.
    Brown, Nicola J.
    Hebbes, Christopher P.
    Guerrini, Remo
    Calo, Girolamo
    Reilly, Charles S.
    Lambert, David G.
    PLOS ONE, 2013, 8 (09):
  • [7] UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice
    Nazzaro, Cristiano
    Rizzi, Anna
    Salvadori, Severo
    Guerrini, Remo
    Regoli, Domenico
    Zeilhofer, Hanns Ulrich
    Calo, Girolamo
    PEPTIDES, 2007, 28 (03) : 663 - 669
  • [8] Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors
    Bigoni, R
    Calò, G
    Rizzi, A
    Okawa, H
    Regoli, D
    Smart, D
    Lambert, DG
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2002, 80 (05) : 407 - 412
  • [9] [3H]ac-RYYRWK-NH2, a novel specific radioligand for the nociceptin/orphanin FQ receptor
    Christian Thomsen
    Jacob S. Valsborg
    Jette Platou
    Joel Martin
    Christian Foged
    Nils L. Johansen
    Uffe B. Olsen
    Kjeld Madsen
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2000, 362 : 538 - 545
  • [10] Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice
    E. C. Gavioli
    C. W. Vaughan
    G. Marzola
    R. Guerrini
    V. A. Mitchell
    S. Zucchini
    T. C. M. De Lima
    G. A. Rae
    S. Salvadori
    D. Regoli
    G. Calo’
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2004, 369 : 547 - 553